The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• UGI neoplastic lesions \> 10mm

‣ Lesions for ESD limited to the mucosal and/or submucosal layer OR

⁃ Lesions for EFTR limited to the muscularis propria layer OR

⁃ Lesions for STER limited to the submucosal and/or muscularis propria layer

• Aged 18 years or older

Locations
Other Locations
Australia
Westmead Hospital
RECRUITING
Sydney
Contact Information
Primary
Michael Bourke
michael@citywestgastro.com.au
02 8890 5555
Time Frame
Start Date: 2023-03-14
Estimated Completion Date: 2028-09-14
Participants
Target number of participants: 500
Treatments
Patient with Gastrointestinal neoplasm
Pt referred for resection of gastrointestinal neoplasm. Observational data collected from endoscopic submucosal dissection (ESD), submucosal-tunnelling endoscopic resection (STER) or endoscopic full-thickness resection (EFTR) of gastrointestinal neoplasm
Sponsors
Leads: Western Sydney Local Health District

This content was sourced from clinicaltrials.gov